Showing 1 - 20 results of 344 for search '"pituitary"', query time: 0.07s Refine Results
  1. 1
  2. 2

    Pituitary adenoma: a literature review by A. Sidaraitė, B. Glebauskienė, R. Liutkevičienė

    Published 2018-03-01
    Subjects: “…pituitary adenoma…”
    Get full text
    Article
  3. 3

    MicroRNAs in Human Pituitary Adenomas by Xu-Hui Li, Elaine Lu Wang, Hai-Meng Zhou, Katsuhiko Yoshimoto, Zhi Rong Qian

    Published 2014-01-01
    “…Deregulated miRNAs and their targets contribute to pituitary adenomas progression and are associated with cell cycle control, apoptosis, invasion, and pharmacological treatment of pituitary adenomas. …”
    Get full text
    Article
  4. 4
  5. 5

    Stereotactic Irradiation of GH-Secreting Pituitary Adenomas by G. Minniti, C. Scaringi, D. Amelio, R. Maurizi Enrici

    Published 2012-01-01
    “…We have reviewed the recent published literature on stereotactic techniques for GH-secreting pituitary tumors with the aim to define the efficacy and potential adverse effects of each of these techniques.…”
    Get full text
    Article
  6. 6
  7. 7
  8. 8

    Pituitary Adenoma and Hyperprolactinemia Accompanied by Idiopathic Granulomatous Mastitis by Sebahattin Destek, Vahit Onur Gul, Serkan Ahioglu, Kursat Rahmi Serin

    Published 2017-01-01
    “…Prolactin level was above the reference range, and pituitary MRI revealed a pituitary prolactinoma. After treatment with prolactin inhibitors, IGM also improved with hyperprolactinemia. …”
    Get full text
    Article
  9. 9
  10. 10
  11. 11
  12. 12

    Role of MMP-2 (-1306 C/T) Polymorphism in Pituitary Adenoma by Brigita Glebauskiene, Rasa Liutkeviciene, Alvita Vilkeviciute, Loresa Kriauciuniene, Giedrimantas Bernotas, Arimantas Tamasauskas, Dalia Zaliuniene

    Published 2016-01-01
    “…To determine if the frequency of the genotype of MMP-2 (-1306 C/T) Rs243865 has an influence on the development of pituitary adenoma (PA). Methods. The study enrolled n=84 patients with PA and a random sample of the population n=318 (reference group). …”
    Get full text
    Article
  13. 13

    Two Cases of Pituitary Stalk Interruption Syndrome in Syrian Children by Ibrahim Alali, Reem Saad, Younes Kabalan

    Published 2020-01-01
    “…It can be diagnosed by magnetic resonance imaging (MRI) of the hypothalamus and pituitary gland, showing an ectopic or absent posterior pituitary, an absent or interrupted pituitary stalk, or small anterior pituitary, in combination with growth hormone or other pituitary hormone deficiencies. …”
    Get full text
    Article
  14. 14

    Resistin Regulates Pituitary Lipid Metabolism and Inflammation In Vivo and In Vitro by F. Rodriguez-Pacheco, M. G. Novelle, M. J. Vazquez, E. Garcia-Escobar, F. Soriguer, G. Rojo-Martinez, E. García-Fuentes, M. M. Malagon, C. Dieguez

    Published 2013-01-01
    “…Although adipose tissue is the primary source of resistin, it is also expressed in other tissues, including the pituitary. The aim of this study is to investigate the possible action of resistin on the lipid metabolism in the pituitary gland in vivo (rats in two different nutritional status, fed and fast, treated with resistin on acute and a chronic way) and in vitro (adenopituitary cell cultures treated with the adipokine). …”
    Get full text
    Article
  15. 15
  16. 16
  17. 17

    FSH and TSH in the Regulation of Bone Mass: The Pituitary/Immune/Bone Axis by Graziana Colaianni, Concetta Cuscito, Silvia Colucci

    Published 2013-01-01
    “…Recent evidences have highlighted that the pituitary hormones have profound effects on bone, so that the pituitary-bone axis is now becoming an important issue in the skeletal biology. …”
    Get full text
    Article
  18. 18

    Calcium/Calmodulin-Dependent Kinases in the Hypothalamus, Pituitary, and Pineal Gland: An Overview by Vincenzo Cimini, Susan Van Noorden, Cristina Terlizzi, Giovanna Giuseppina Altobelli

    Published 2022-01-01
    “…In the teleost anterior pituitary, the activation of CaMKII induces the expression of somatolactin by glucagon b. …”
    Get full text
    Article
  19. 19
  20. 20

    Cardiovascular Risk and Metabolic Syndrome Characteristics in Patients with Nonfunctional Pituitary Macroadenoma by Guadalupe Vargas-Ortega, Baldomero González-Virla, Lourdes Balcázar-Hernández, Oriana Nieto-Guzmán, Ana Pamela Garrido-Mendoza, Marco Antonio Flores-Maya, Victoria Mendoza-Zubieta

    Published 2018-01-01
    “…An elevated incidence of type 2 diabetes and cardiovascular disease (CVD) has been reported in patients with nonfunctional pituitary macroadenoma (NFPMA). There is no information about metabolic syndrome and cardiovascular risk in patients with NFPMA in our population. …”
    Get full text
    Article